preval
allerg
diseas
allerg
rhiniti
asthma
atop
dermat
ad
increas
dramat
develop
develop
countri
world
health
organ
estim
million
peopl
world
popul
billion
allerg
asthma
advers
affect
qualiti
life
socioeconom
welfar
societi
ad
one
frequent
chronic
inflammatori
skin
diseas
affect
children
adult
worldwid
also
name
eczema
ad
common
type
chronic
allerg
skin
diseas
occur
age
affect
infant
children
adult
worldwid
preval
ad
increas
case
occur
age
ad
infant
prone
subsequ
develop
allerg
asthma
allerg
rhiniti
childhood
ad
longlast
skin
disord
patient
may
suffer
episod
exacerb
remiss
life
typic
symptom
ad
includ
extrem
itchi
inflam
dri
skin
inflam
area
red
swollen
crack
scale
webbi
crust
definit
cure
ad
current
effect
treatment
involv
topic
applic
immunosuppress
steroid
undesir
side
effect
therefor
rise
interest
develop
safer
nonsteroid
immunomodulatori
formula
treatment
ad
tradit
chines
medicin
tcm
becom
accept
increasingli
use
modal
immunomodul
especi
asia
previou
clinic
trial
shown
children
moderatetosever
ad
manifest
significantli
improv
qualiti
life
treatment
tcm
pentaherb
formula
phf
concurr
reduc
use
topic
corticosteroid
find
suggest
phf
could
potenti
altern
adjunct
therapi
ad
phf
contain
five
herb
lonicera
flo
jinyinhua
mentha
herba
bohe
moutan
cortex
danpidp
atractylodi
rhizoma
cangzhu
phellodendri
cortex
huangbai
ratio
group
other
previous
shown
differ
herb
phf
possess
antiinflammatori
activ
exhibit
potenti
therapeut
efficaci
inflammatori
diseas
rheumatoid
arthriti
therefor
phf
formul
evalu
cellular
mechan
antiinflammatori
activ
phf
increas
ratio
danpi
exhibit
greater
inhibitori
effect
releas
cytokin
interleukin
il
human
mast
cell
gallic
acid
ga
acid
potent
antioxid
found
witch
hazel
tea
leav
one
main
ingredi
danpi
ga
shown
possess
antitumorigen
effect
antiinflammatori
activ
nude
mice
human
cell
line
novel
member
cytokin
famili
releas
passiv
cell
necrosi
tissu
damag
character
potent
proinflammatori
cytokin
act
immun
cell
mast
cell
eosinophil
basophil
allerg
inflamm
addit
inflam
skin
lesion
ad
patient
elev
protein
mrna
express
compar
normal
subject
tissu
inflamm
consist
two
essenti
step
adher
leukocyt
vascular
endotheli
cell
migrat
inflammatori
site
via
diapedesi
releas
allerg
inflammatori
chemokin
cytokin
leukocyt
aim
present
studi
elucid
mechan
vitro
antiinflammatori
antiallerg
activ
phf
danpi
ga
via
modul
express
cell
surfac
adhes
molecul
ii
releas
chemokin
cytokin
allergyrel
alarmin
human
basophil
crucial
effector
cell
allerg
inflamm
allerg
asthma
ad
circul
basophil
recruit
inflammatori
tissu
allerg
disord
includ
allerg
asthma
ad
allerg
rhiniti
asthma
exacerb
respons
allergen
inhal
challeng
basophil
markedli
infiltr
allerg
inflammatori
site
sinc
human
basophil
repres
peripher
blood
leukocyt
cell
purifi
peripher
blood
mononuclear
cell
feasibl
obtain
enough
number
basophil
present
vitro
studi
accord
previou
experi
found
repres
basophil
cell
show
similar
result
express
induct
chemokin
cytokin
data
shown
therefor
like
previou
public
adopt
repres
basophil
cell
present
mechanist
studi
cell
treat
variou
concentr
phf
dp
ga
follow
measur
cell
surfac
express
adhes
molecul
shown
figur
phf
dp
ga
could
significantli
suppress
express
intercellular
adhes
molecul
icam
cell
dosedepend
manner
p
reduc
express
activ
cell
suggest
phf
dp
ga
may
inhibit
endotheli
transmigr
basophil
inflam
site
dampen
subsequ
allerg
respons
chemokin
monocyt
chemotact
regul
normal
cell
express
secretedrant
known
associ
inflamm
known
adassoci
chemokin
recruit
dendrit
cell
monocyt
memori
cell
circul
inflammatori
site
potent
chemoattract
immun
cell
especi
neutrophil
inflam
site
chemotact
helper
type
cell
eosinophil
basophil
figur
show
releas
cell
significantli
suppress
treatment
phf
dp
ga
dosedepend
suppress
releas
phf
ga
figur
suppress
releas
inflammationrel
chemokin
cell
may
reduc
infiltr
immun
cell
th
cell
eosinophil
basophil
macrophag
inflam
site
therebi
lessen
subsequ
inflamm
allerg
respons
th
cell
includ
play
import
role
cellmedi
immun
humor
immun
respect
sinc
cell
respons
ige
product
sensit
activ
mast
cell
type
hypersensit
suppress
releas
chemokin
phf
dp
ga
subsequ
reduc
infiltr
cell
inflammatori
site
henc
allerg
inflamm
proinflammatori
cytokin
produc
cell
macrophag
inflammatori
site
play
import
role
regul
immun
respons
immedi
latephas
allerg
inflamm
cell
activ
combin
effect
solubl
lead
transit
acut
chronic
inflamm
mean
switch
transmigr
neutrophil
monocytesmacrophag
inflam
site
shown
figur
dosedepend
suppress
releas
phf
dp
ga
cell
may
reduc
progress
acut
chronic
inflamm
allerg
diseas
mapk
jnk
involv
intracellular
signal
pathway
contribut
inflammatori
respons
granulocyt
basophil
eosinophil
mapk
jnk
play
crucial
role
regul
cell
apoptosi
cell
prolifer
inflammatori
cytokin
releas
bound
inhibitori
protein
key
regul
proinflammatori
mediat
express
inflammatori
cytokin
induct
lymphocyt
granulocyt
macrophag
fibroblast
level
phosphoryl
directli
relat
releas
activ
subsequ
transloc
nucleu
activ
gene
transcript
cytokin
chemokin
adhes
molecul
figur
show
phosphoryl
mapk
jnk
cell
significantli
inhibit
ga
p
howev
ga
exhibit
effect
phosphoryl
extracellular
signal
regul
kinas
erk
data
shown
therefor
reduct
phosphoryl
mapk
jnk
ga
could
underli
intracellular
mechan
account
suppress
express
releas
figur
sinc
ga
dose
could
potent
suppress
phosphoryl
ga
show
signific
suppress
phosphoryl
p
howev
mean
phosphoryl
ga
still
lower
ga
sinc
phf
dp
complex
heterogen
mixtur
singl
purifi
compound
could
difficult
interpret
effect
individu
intracellular
signal
pathway
therefor
phf
danpi
investig
effect
intracellular
signal
molecul
present
studi
dexamethason
potent
synthet
member
glucocorticoid
class
steroid
drug
usual
prescrib
patient
ad
resolv
tissu
inflamm
report
dexamethason
promot
eosinophil
apoptosi
inhibit
basophil
migrat
investig
express
adhes
molecul
chemokin
cytokin
cell
treat
combin
use
dexamethason
variou
concentr
natur
product
phf
dp
ga
shown
figur
combin
use
low
concentr
dexamethason
ga
could
suppress
express
cell
compar
use
ga
dexamethason
alon
howev
higher
concentr
dexamethason
togeth
ga
exhibit
signific
suppress
compar
ga
dexamethason
alon
data
shown
addit
phf
dp
show
similar
enhanc
suppress
effect
express
data
shown
result
suggest
phf
dp
ga
could
use
togeth
lower
dose
dexamethason
resolut
inflamm
patient
allerg
diseas
ad
therebi
promot
therapeut
efficaci
lessen
advers
side
effect
steroid
drug
medium
fetal
bovin
serum
fb
purchas
life
technolog
corp
carlsbad
ca
usa
fitc
conjug
goat
antimous
igg
dexamethason
pb
dimethyl
sulfoxid
dmso
ga
purchas
sigmaaldrich
co
st
loui
mo
usa
recombin
human
fitcconjug
mous
antihuman
antihuman
monoclon
antibodi
purchas
r
system
inc
minneapoli
mn
usa
purifi
mous
isotyp
control
mous
antihuman
mous
antijnk
mous
purchas
bd
pharmingen
corp
san
diego
ca
usa
phf
dp
suppli
institut
chines
medicin
chines
univers
hong
kong
water
extract
prepar
hong
kong
biotechnolog
institut
hong
kong
phf
extract
lonicera
flo
g
mentha
herba
g
moutan
cortex
g
atractylodi
rhizoma
g
phellodendri
cortex
g
reflux
distil
water
ml
h
whole
process
repeat
twice
three
batch
water
extract
mix
togeth
centrifug
remov
herbal
debri
final
combin
extract
vacuum
dri
form
herbal
powder
store
desicc
use
process
fulfil
good
manufactur
practic
accord
australian
therapeut
good
administr
standard
ga
purchas
sigmaaldrich
dosag
dp
use
studi
base
previou
highperform
liquid
chromatographi
hplc
analysi
amount
ga
present
dp
ww
henc
dosag
ga
use
experi
rang
phf
danpi
ga
use
vitro
studi
weigh
dissolv
pyrogenfre
phosphat
buffer
salin
pb
h
centrifug
rpm
min
supernat
filter
polyethersulphon
filter
herbal
debri
dri
overnight
weigh
solut
store
concentr
solut
weight
mass
dissolv
pb
mass
herbal
debri
volum
pb
use
hplc
analys
perform
use
hewlett
packard
agil
seri
hplc
system
equip
al
autosampl
diod
array
detector
agil
technolog
santa
clara
ca
usa
calibr
curv
ga
prepar
use
standard
solut
contain
ga
danpi
aqueou
extract
prepar
doubl
distil
water
sampl
solut
inject
onto
ultraspher
od
column
mm
id
particl
size
beckman
instrument
inc
fullerton
ca
usa
solvent
prefilt
millipor
filter
disk
millipor
corp
billerica
usa
degass
gradient
elut
carri
use
follow
solvent
system
mobil
phase
mobil
phase
distil
waterphosphor
acid
vv
analys
perform
min
flow
rate
use
mlmin
detect
perform
nm
sampl
inject
column
filtrat
filter
disk
system
monitor
comput
equip
karat
softwar
beckman
data
collect
integr
analysi
ga
quantiti
human
basophil
cell
line
cell
american
type
cultur
collect
manassa
va
usa
maintain
medium
supplement
vv
fb
complet
medium
cell
incub
atmospher
air
enrich
vv
cell
confluenc
cell
dispers
complet
medium
final
cell
concentr
cellsml
treatment
cell
seed
plate
densiti
cell
complet
medium
per
well
preactiv
ng
h
follow
treatment
variou
concentr
phf
dp
ga
presenc
h
cell
use
detect
express
adhes
molecul
supernat
collect
subject
bd
cytometr
bead
array
cba
assay
allerg
inflammationrel
chemokin
cytokin
see
use
flow
cytometri
analysi
adhes
molecul
cell
wash
suspend
cold
pb
follow
block
human
pool
serum
min
incub
fitcconjug
mous
antihuman
mous
isotyp
r
system
min
dark
wash
cell
resuspend
pb
flow
cytometr
analysi
analysi
chemokin
cytokin
supernat
obtain
subject
beadbas
multiplex
cba
immunoassay
human
inflammatori
kit
human
chemokin
kit
captur
bead
contain
monoclon
antibodi
individu
cytokin
chemokin
supernat
incub
differ
captur
bead
mixtur
phycoerythrinconjug
detect
antibodi
three
hour
room
temperatur
constant
shake
incub
bead
wash
resuspend
wash
buffer
sampl
subsequ
analyz
bd
facscalibur
flow
cytomet
bd
bioscienc
san
jose
ca
usa
bd
cba
analysi
softwar
analysi
intracellular
express
phosphoryl
signal
molecul
cell
seed
cultur
plate
preactiv
ng
min
h
follow
treatment
ga
cell
fix
paraformaldehyd
min
centrifug
cell
permeabil
icecold
methanol
min
stain
fitcconjug
mous
antihuman
phosphoryl
phosphoryl
jnk
phosphoryl
mapk
phosphoryl
mous
antibodi
bd
pharmingen
min
dark
cell
wash
resuspend
subject
analysi
express
surfac
adhes
molecul
intracellular
phosphoryl
signal
molecul
chemokin
cytokin
analyz
flow
cytometri
facscalibur
mean
fluoresc
intens
mfi
includ
chang
target
molecul
express
individu
cell
percentag
cell
express
target
molecul
data
express
mean
sem
differ
group
assess
student
ttest
probabl
p
consid
significantli
differ
anova
indic
signific
differ
bonferroni
post
hoc
test
use
assess
differ
group
analys
perform
use
statist
packag
social
scienc
statist
softwar
window
version
spss
inc
chicago
il
usa
sinc
immunopatholog
mechan
allerg
diseas
ad
complex
involv
cellular
humor
compon
immun
system
result
suggest
tcm
pentaherb
formula
herbal
compon
danpi
bioactiv
compound
gallic
acid
suppress
inflamm
elicit
allerg
inflammationrel
effector
cell
name
basophil
inhibit
express
adhes
molecul
allergyrel
cytokin
chemokin
present
studi
also
provid
evid
intracellular
mechan
includ
mpak
pathway
ga
could
modul
function
basophil
sinc
corticosteroid
present
pentaherb
formula
combin
use
lower
dose
dexamethason
natur
product
pentaherb
formula
danpi
gallic
acid
may
enhanc
develop
novel
therapeut
modal
allerg
inflammatori
diseas
ad
high
potenc
less
side
effect
